sees fy year-five earnings per share $num-three to $num-one .
qtr-two earnings per share $num-two.
sees fy year-five revenue $num-one billion to $num-two billion.
qtr-two revenue $num-one million versus refinitiv ibes estimate of $770.3 million.
maximus - reinstated guidance for fiscal year-five with diluted earnings per share to range between $num-three and $num-one.
maximus - experienced in quarter, covid pandemic related write-down of approximately $num-one million or $num-two of diluted eps.
maximus - experienced in quarter, covid pandemic related write-down of approximately $num-one million or $num-two of diluted eps.
change order for about $num-one million or $num-two of diluted earnings per share was signed after [date], year-five, in u.s.
health & human services segment.
sees year-five cash flows from operations to range between $num-one and $num-two million, free cash flow between $num-three and $num-one million.